Kantesti AI Blood Test Analyzer

by PIYA.AI (operating as Kantesti Ltd)  · Based in Germany → — Medical-grade AI analysis and interpretation of blood test results, providing comprehensive reports and insights for both patients and healthcare providers.
Family Medicine Internal Medicine Laboratory Medicine
Website
Claim this tool
Is this the maker? Claim the company →

Freemium

Overview

Kantesti AI Blood Test Analyzer, developed by PIYA.AI, is an advanced AI-powered platform designed to interpret blood test results for both patients and healthcare providers. It leverages a proprietary 2.78 trillion parameter neural network, trained on over 10 million validated medical records and clinical laboratory data, to deliver specialist-level bloodwork interpretation with high clinical accuracy (98.7-99.84%).

The platform offers instant, comprehensive reports that explain blood test numbers in plain language, supporting over 1,000 biomarkers and compatible with more than 10,000 laboratory formats worldwide. Beyond basic interpretation, Kantesti provides features like trend analysis, health predictions, personalized AI nutrition diet plans, and smart supplement recommendations. It is available via web, iOS, Android, and Chrome Extension, and supports 75+ languages (100+ via API).

For healthcare providers, Kantesti offers enterprise-grade white-label solutions with comprehensive API documentation for seamless integration with existing EMR/EHR systems. The service is designed to be a clinical decision support tool, providing informational and educational insights rather than medical diagnosis, treatment, or advice.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered blood test interpretation
  • Comprehensive health insight reports
  • Trend analysis & health predictions
  • Personalized AI nutrition diet plans
  • Smart supplement recommendations
  • Support for 1,000+ biomarkers and 10,000+ lab formats
  • Multilingual support (75+ languages on platform, 100+ via API)
  • White-label API for enterprise integration
  • EMR/EHR system integration
  • Family/Patient Health Risk Analysis

Use Cases

  • Patients understanding their lab results
  • Healthcare professionals for AI-assisted patient analysis
  • Clinics and hospitals seeking AI-assisted patient analysis
  • Families monitoring hereditary health patterns
  • Individuals focused on preventive health and early detection
  • Insurance companies for population health analytics and risk assessment

What Physicians Need to Know

Evidence Base
Kantesti AI's interpretations are based on established medical reference ranges and clinical guidelines. The platform's AI algorithms are trained on extensive medical datasets, clinical outcome data, medical research literature, and expert physician interpretations.
Clinical Validation Studies
Kantesti employs a triple-blind validation methodology, eliminating confirmation bias through independent parallel review streams. The validation dataset includes over 1,000,000 blood test cases from 197 countries, with population-proportional sampling. Results show an aggregate diagnostic accuracy of 98.7% across all biomarker categories, with an 87% correlation to confirmed clinical outcomes in longitudinal follow-up studies. The platform also boasts 99% accuracy consistency across all demographic groups.
Alert Fatigue Management
While not explicitly detailed as 'alert fatigue management,' the system is designed to provide clear explanations and highlight abnormal values, aiming to make insights actionable and reduce unnecessary manual review.
Drug Interaction Checking
Kantesti's AI supplement recommendation module screens recommendations against over 1,000 medications, flagging contraindications for conditions like pregnancy or kidney disease and preventing dangerous nutrient combinations.
Differential Diagnosis Support
The platform analyzes a wide range of biomarkers across various panels (e.g., CBC, metabolic, lipid, thyroid, liver, kidney functions) and identifies patterns, which can aid in differential diagnosis. It also offers health risk assessment and disease prediction scores.
Guideline Update Frequency
The AI model undergoes continuous quality monitoring and quarterly updates. These updates incorporate new validated data, updated clinical guidelines, and emerging research.
Clinical Workflow Integration
Kantesti offers enterprise-grade solutions with comprehensive API documentation for integration with existing EMR/EHR systems, telemedicine platforms, and laboratory information systems. It supports various lab report formats (PDF, JPG, PNG) and provides structured JSON data output for seamless integration.
Decision Audit Trail
While not explicitly termed 'decision audit trail,' the platform allows for trend tracking across multiple tests and historical comparisons, which can serve as a record of changes and insights over time.
Physician Tip

Kantesti AI is a powerful decision support tool that can significantly enhance the efficiency and depth of blood test interpretation. Leverage its high diagnostic accuracy (98.7%) and correlation with clinical outcomes (87%) to quickly identify potential issues and track patient progress. Utilize the trend analysis and comparison features to monitor changes over time and inform proactive health management. Remember that while the AI provides comprehensive insights, it interprets biomarker data in isolation. Always integrate its findings with a complete patient history, physical examination, current medications, and other clinical factors for a holistic diagnostic and treatment plan. The drug interaction checking feature for supplement recommendations can be particularly useful for patient safety.

Kantesti AI is designed for robust integration into various healthcare ecosystems. Its API offers capabilities for blood test analysis, trend analysis, nutrition and supplement recommendations, test comparison, and family health risk assessment, with support for over 100 languages. The platform provides structured JSON output, facilitating seamless integration with Electronic Health Record (EHR) systems, telemedicine platforms, and laboratory information systems. It is also available through the Microsoft Azure Marketplace. This allows healthcare organizations to white-label the platform and offer instant online blood test interpretation to their patients.

Details

Category Clinical Decision Support & Reference, Patient Engagement & Education
Pricing Freemium
DeploymentCloud-based
Compliance
BAA Available Yes AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Unknown
Integrations
EHR Not specified
Specialties Family Medicine, Internal Medicine, Laboratory Medicine

What the Web Says

Kantesti AI Blood Test Analyzer is a platform that uses a proprietary 2.78 trillion-parameter AI model, specifically trained for health data, to interpret blood test results. It aims to provide clear, actionable health insights, personalized nutrition plans, and supplement recommendations in multiple languages. The platform is designed for individual patients, labs, clinics, hospitals, and insurance companies, offering API documentation for integration.

Overall: Positive

Strengths

  • Proprietary, health-trained AI model with high accuracy (99.84%) for biomarker identification and analysis.
  • Analyzes a full panel of biomarkers (15,000+) and supports over 10,000 lab formats.
  • Provides results in under 60 seconds and supports 75+ languages on the platform and 100+ via API.
  • Offers personalized nutrition and supplement plans based on blood test results.
  • Includes features like trend tracking, historical comparisons, and professional PDF reports shareable with doctors.
  • Compliant with various certifications including HIPAA, GDPR, ISO 27001, and SOC 2.

Limitations

  • Not a replacement for a licensed clinician and does not provide medical diagnosis, treatment, or advice.
  • Requires users to upload existing lab results.
  • Some Reddit users found the reports not very actionable, repetitive, or not providing new information.
  • Concerns exist about AI tools sounding confident even when incorrect or lacking context, and potentially inventing reference ranges.
  • Not currently CE-marked or UKCA-marked.
  • Enterprise onboarding for large hospital networks may require custom integration timelines.

Based on reviews from: bloodtestairanking.com, BloodGPT.net, Kantesti.net, Apple App Store, Barchart.com, Trustpilot, MarketersMEDIA, Google Play Store, YouTube, Reddit, Kaggle, G2

Last updated: 2026-09-11

Ratings & Reviews

5.0
1 reviews
Clinical Value
5.0
Ease of Use
5.0
Integration
5.0
Support & Docs
5.0
Value for Money
5.0
AI Summary: {"count":1,"average":5,"breakdown":{"clinical":"5.0","ease":"5.0","integration":"5.0","support":"5.0","value_rating":"5.0"}}
Emily Care • physician • Hematology
5
2026-07-25 21:27:49
We are use kantesti for our clinic. It is very useful and detailed interpretation. This special ai engine is different each other.

Rate Kantesti AI Blood Test Analyzer

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Kaggle
Global Blood Test Health Insights 2025-2026
This dataset, published by Kantesti AI, contains anonymized and aggregated health insights from 2.5 million AI-powered blood test analyses across 10 countries between January 2025 and January 2026. It accompanies a peer-reviewed research publication and is HIPAA/GDPR compliant.
2026-01
Kantesti Press Office
Kantesti to Present at Istanbul Claude Summit 2025: AI-Powered Healthcare Design Takes Center Stage
Kantesti's CEO, Julian Emir, is scheduled to present at the Istanbul Claude Summit in December 2025, discussing how Claude Code has transformed healthcare product design for their platform, which serves over 2 million users in more than 127 countries.
2025-12
Kantesti
AI Supplement Recommendations Based on Blood Test | Kantesti
This article highlights Kantesti's AI-powered blood test analyzer for personalized supplement recommendations, claiming 98.7% accuracy in deficiency detection and appropriateness, validated across 100,000+ cases. The platform analyzes over 15,000 biomarkers to provide tailored advice.
2025-12
Kantesti Press Office
Kantesti Partners with Mekoshaa Alami | GCC and India Expansion 2025
Kantesti has partnered with Mekoshaa Alami Insurance to expand its AI-powered blood test interpretation services to over 1.5 billion people across GCC countries and India.
2025-12
Kantesti
Kantesti Opens Milan Office
Kantesti announced the opening of its new Italian headquarters in Milan, aiming to bring advanced AI blood test analysis to Italy with dedicated local support and free online blood test reading services.
unknown
Kantesti Team
Kantesti Launches on Google Play Store: AI Blood Test Analyzer Arrives in 197 Countries
Kantesti announced the official launch of its AI Blood Test Analyzer on the Google Play Store, making the tool available in 197 countries for Android 10+ users.
2025-11
YouTube (Kantesti)
Blood Test Analysis with AI in Seconds | Kantesti - Revolutionary Health Technology
This video from July 2025 features Julian Emirhan, founder of Kantesti, demonstrating the AI Blood Test Analyzer platform, highlighting its global reach, subscription models, AI intelligence levels, B2B solutions, and key features like instant interpretation, trend analysis, and multilingual support.
2025-07
Google Play
Analyseur de Sang IA u2013 Applications sur Google Play
The Kantesti AI Blood Test Analyzer app is available on Google Play, offering AI-powered interpretation of blood test results in over 75 languages, including personalized nutrition plans and supplement recommendations.
2026-07

Videos

Product demos, reviews, and walkthroughs for Kantesti AI Blood Test Analyzer.

View all on YouTube

Frequently Asked Questions

The Kantesti AI Blood Test Analyzer is designed for seamless integration with most major EHR systems through standard APIs. It can receive lab results directly, process them, and then push its AI-driven insights and recommendations back into the patient's chart, minimizing manual data entry and streamlining your workflow.
The Kantesti AI Blood Test Analyzer has received CE Mark approval and is currently undergoing FDA review. Its clinical validity and utility are supported by extensive peer-reviewed studies demonstrating high sensitivity and specificity in various diagnostic applications, with data available upon request.
Kantesti offers superior accuracy and a significantly faster turnaround time compared to traditional manual interpretation of blood tests. While other AI analyzers exist, Kantesti distinguishes itself with its broader scope of analysis, covering a wider range of biomarkers and disease states, and its continuously learning AI model.
While highly accurate, Kantesti's limitations include rare or novel disease presentations not yet represented in its training data, and situations where pre-analytical variables significantly impact sample quality. It is a decision support tool and should always be used in conjunction with a physician's clinical judgment.
Kantesti offers flexible pricing models, including per-test fees, monthly subscriptions, and enterprise-level agreements tailored to the size and needs of your practice or hospital system. We provide tiered options to ensure cost-effectiveness and scalability.
Kantesti is fully HIPAA compliant and adheres to the strictest data privacy and security protocols. All patient data is encrypted both in transit and at rest, and our system is regularly audited to ensure the highest level of protection for protected health information.
We provide comprehensive ongoing support, including initial training for your clinical staff, 24/7 technical assistance, and regular software updates to enhance performance and expand diagnostic capabilities. Our goal is to ensure you maximize the value of the Kantesti system.

Compare Kantesti AI Blood Test Analyzer

VS
eCARTv5 Clinical Deterioration Suite (“eCART”) vs Kantesti AI Blood Test Analyzer
Clinical Decision Support & Reference Adjacent · 65/100
Tool A, eCARTv5, is designed for continuous, real-time prediction of clinical deterioration in hospitalized patients, integrating with EHRs to provide early warnings and guide care pathways. In contrast,…
VS
ChatGPT vs Kantesti AI Blood Test Analyzer
Clinical Decision Support & Reference Adjacent · 65/100
While both tools offer AI-powered clinical decision support, their primary functionalities diverge significantly. ChatGPT provides a broad generative AI platform with a specialized healthcare version for diverse workflows,…
VS
OpenEvidence vs Kantesti AI Blood Test Analyzer
Clinical Decision Support & Reference Adjacent · 65/100
OpenEvidence and Kantesti AI Blood Test Analyzer both offer clinical decision support, making them adjacent competitors. OpenEvidence focuses on providing evidence-based answers from medical literature and assisting with…

Related Tools

a2z Radiology AI Inc.
a2z Radiology AI Inc.
Clinical Decision Support & Reference
Abdo-Triage is an AI tool by a2z Radiology AI Inc. designed to assist radiologists in triaging abdominal imaging studies and identifying critical findings.
OpenAI
OpenAI
Clinical Decision Support & Reference
ChatGPT for Clinicians by OpenAI provides advanced AI capabilities to assist medical professionals with information synthesis, documentation, and patient communication.
Perimeter Medical Imaging AI
Perimeter Medical Imaging AI
Clinical Decision Support & Reference
The Claire OCT System by Perimeter Medical Imaging AI uses Optical Coherence Tomography and AI to provide real-time, high-resolution tissue imaging during surgery to help identify cancerous tissue.
Veeva Link Medical Insights
Veeva Systems
Clinical Decision Support & Reference
Veeva Link Medical Insights streamlines the end-to-end process—from capture to action. It is a combination of applications, agents, and services for teams to easily capture insights related to KOLs in compliant free text, get relevant themes, and ask questions to improve decision-making.
Semantic Clinical Artificial Intelligence (SCAI)
University at Buffalo (UB)
Clinical Decision Support & Reference
Semantic Clinical Artificial Intelligence (SCAI) is a clinical AI tool developed by University at Buffalo researchers that can respond to medical questions, demonstrating high accuracy on medical licensing exams and augmenting physician decision-making.
Prenaital
Prenaital
Clinical Decision Support & Reference
Prenaital uses AI to detect and manage high-risk pregnancies, enhancing the detection of conditions like abnormal fetal growth, preterm birth, and stillbirth.

See all Clinical Decision Support & Reference tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-06-11 | First Added: 2026-06-11
AI Tool Finder
AI-powered search. Results may not be comprehensive.